LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 12 of 15: Mean cell count and mean normalized growth rate inhibition values across biological replicate 2. - Dataset (ID:20249)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Timepoint | Timepoint Unit | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|---|
Hs 578T | Mitoxantrone | 0.37 | uM | LJP5 | 72 | hr | 765 | 628 | 3148 | 0.1995 | -0.0923 |
Hs 578T | Pelitinib | 10 | uM | LJP5 | 72 | hr | 765 | 628 | 3148 | 0.1996 | -0.0922 |
MCF 10A | Mitoxantrone | 3.33 | uM | LJP6 | 72 | hr | 1694 | 630 | 11217 | 0.0562 | -0.3070 |
BT-20 | Torin2 | 3.33 | uM | LJP5 | 72 | hr | 1334 | 631 | 4033 | 0.1566 | -0.3746 |
Hs 578T | HG-5-113-01 | 10 | uM | LJP5 | 72 | hr | 765 | 631 | 3148 | 0.2006 | -0.0900 |
Hs 578T | AZD7762 | 0.12 | uM | LJP6 | 72 | hr | 765 | 632 | 3101 | 0.2040 | -0.0903 |
MDA-MB-231 | LDN-193189 | 10 | uM | LJP5 | 72 | hr | 1311 | 641 | 5079 | 0.1260 | -0.3126 |
MDA-MB-231 | Fedratinib | 10 | uM | LJP5 | 72 | hr | 1311 | 642 | 5079 | 0.1263 | -0.3080 |
Hs 578T | PD0325901 | 10 | uM | LJP5 | 72 | hr | 765 | 643 | 3148 | 0.2045 | -0.0817 |
BT-20 | Mitoxantrone | 1.11 | uM | LJP6 | 72 | hr | 1334 | 645 | 3925 | 0.1646 | -0.3742 |
Hs 578T | R406 | 10 | uM | LJP6 | 72 | hr | 765 | 646 | 3101 | 0.2084 | -0.0805 |
BT-20 | Withaferin A | 3.33 | uM | LJP5 | 72 | hr | 1334 | 647 | 4033 | 0.1605 | -0.3650 |
Hs 578T | NVP-AEW541 | 10 | uM | LJP5 | 72 | hr | 765 | 647 | 3148 | 0.2055 | -0.0789 |
BT-20 | GW843682X | 10 | uM | LJP6 | 72 | hr | 1334 | 648 | 3925 | 0.1652 | -0.3713 |
Hs 578T | Luminespib | 3.33 | uM | LJP5 | 72 | hr | 765 | 649 | 3148 | 0.2062 | -0.0777 |
MDA-MB-231 | AZD 5438 | 10 | uM | LJP6 | 72 | hr | 1311 | 652 | 4935 | 0.1322 | -0.3061 |
Hs 578T | WYE-125132 | 10 | uM | LJP6 | 72 | hr | 765 | 658 | 3101 | 0.2124 | -0.0717 |
MCF7 | CGP60474 | 0.12 | uM | LJP6 | 72 | hr | 1389 | 659 | 5445 | 0.1217 | -0.3150 |
Hs 578T | Mitoxantrone | 0.37 | uM | LJP6 | 72 | hr | 765 | 661 | 3101 | 0.2132 | -0.0696 |
Hs 578T | Crizotinib | 10 | uM | LJP5 | 72 | hr | 765 | 662 | 3148 | 0.2103 | -0.0696 |
Hs 578T | Nilotinib | 10 | uM | LJP5 | 72 | hr | 765 | 662 | 3148 | 0.2105 | -0.0684 |
Hs 578T | Luminespib | 0.37 | uM | LJP5 | 72 | hr | 765 | 664 | 3148 | 0.2111 | -0.0667 |
MCF7 | PF431396 | 10 | uM | LJP5 | 72 | hr | 1389 | 665 | 5905 | 0.1127 | -0.2973 |
BT-20 | Torin2 | 10 | uM | LJP5 | 72 | hr | 1334 | 667 | 4033 | 0.1658 | -0.3523 |
Hs 578T | Mitoxantrone | 0.12 | uM | LJP6 | 72 | hr | 765 | 669 | 3101 | 0.2156 | -0.0645 |